Recently, studies indicated consistent results about the relationship between high ZFAS1 expression and poorer prognosis in CRC, GC, HCC, glioma, melanoma and NSCLC [14, 15, 17, 18, 19, 20, 22]. Here, ZFAS1 is linked to glioma.